Aristi Biotech Overview

  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Aristi Biotech General Information


Provider of research and development services intended to focus on pre-clinical development of monoclonal antibodies and the generation of protein. The company's research and development services works on antibody research such as monoclonal antibody generation and cell line development, enabling clients to manufacture high quality and high titre producing cell lines.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Yalelaan 62
  • Life Science Incubator
  • 3584 CM Utrecht
  • Netherlands
+31 085 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Aristi Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jul-2017 Completed Out of Business
2. Accelerator/Incubator Completed Startup
1. Grant 03-Feb-2016 Completed Startup
To view Aristi Biotech’s complete valuation and funding history, request access »